Cargando…

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

BACKGROUND: We aimed to evaluate the clinical relevance of p53 and p73 isoforms that modulate the function of p53. METHODS: This prospective multicentre study included 154 patients with stage III and IV serous ovarian cancer. A functional yeast-based assay and subsequent sequencing were performed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofstetter, G, Berger, A, Schuster, E, Wolf, A, Hager, G, Vergote, I, Cadron, I, Sehouli, J, Braicu, E I, Mahner, S, Speiser, P, Marth, C, Zeimet, A G, Ulmer, H, Zeillinger, R, Concin, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242533/ https://www.ncbi.nlm.nih.gov/pubmed/22009029 http://dx.doi.org/10.1038/bjc.2011.433

Ejemplares similares

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium
por: Ray-Coquard, Isabelle, et al.
Publicado: (2019)

A comparison of four technologies for detecting p53 aggregates in ovarian cancer
por: Heinzl, Nicole, et al.
Publicado: (2022)

Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
por: Trillsch, Fabian, et al.
Publicado: (2013)

Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium
por: Aust, Stefanie, et al.
Publicado: (2014)

A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
por: Pils, Dietmar, et al.
Publicado: (2013)

The Δ133p53 Isoforms, Tuners of the p53 Pathway
por: Joruiz, Sebastien M., et al.
Publicado: (2020)

Δ113p53/Δ133p53: survival and integrity
por: Chen, Jun, et al.
Publicado: (2015)

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
por: Braicu, Elena Ioana, et al.
Publicado: (2014)

The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer
por: Svoboda, Martin, et al.
Publicado: (2018)

Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development
por: Kazantseva, Marina, et al.
Publicado: (2018)

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008)

Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant
por: Slatter, T L, et al.
Publicado: (2015)

The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer
por: Moore, Hayley C, et al.
Publicado: (2010)

The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential
por: Arsic, Nikola, et al.
Publicado: (2015)

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2020)

TP53 drives invasion through expression of its Δ133p53β variant
por: Gadea, Gilles, et al.
Publicado: (2016)

Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study
por: Watrowski, Rafał, et al.
Publicado: (2022)

Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer
por: Mungenast, Felicitas, et al.
Publicado: (2017)

p53MutaGene: an online tool to estimate the effect of p53 mutational status on gene regulation in cancer
por: Amelio, I, et al.
Publicado: (2016)

Δ133p53/FLp53 Predicts Poor Clinical Outcome in Esophageal Squamous Cell Carcinoma
por: Tu, Qimin, et al.
Publicado: (2020)

A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.
por: Speiser, P., et al.
Publicado: (1996)

The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner
por: Arsic, Nikola, et al.
Publicado: (2017)

Δ133p53α, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells
por: Mondal, Abdul M., et al.
Publicado: (2018)

p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming
por: Gong, Lu, et al.
Publicado: (2016)

Correction: The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner
por: Arsic, Nikola, et al.
Publicado: (2017)

Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.
por: Gorgoulis, V. G., et al.
Publicado: (1998)

p73 coordinates with Δ133p53 to promote DNA double-strand break repair
por: Gong, Hongjian, et al.
Publicado: (2018)

Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis
por: Jesus, Alexandra N. Boix De, et al.
Publicado: (2023)

Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53
por: Park, E K, et al.
Publicado: (2015)

Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes
por: Mehta, Sunali Y., et al.
Publicado: (2018)

The association between expression of p53 and aggressiveness of serous adenocarcinoma of the uterine cervix
por: Lee, Sul, et al.
Publicado: (2020)

Glycerol restores p53-dependent radiosensitivity of human head and neck cancer cells bearing mutant p53
por: Ohnishi, K, et al.
Publicado: (2000)

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.
por: Thompson, A. M., et al.
Publicado: (1998)

Increased Δ133p53 mRNA in lung carcinoma corresponds with reduction of p21 expression
por: Fragou, Aikaterini, et al.
Publicado: (2017)

p53 isoforms change p53 paradigm
por: Bourdon, JC
Publicado: (2014)

The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer
por: Kazantseva, Marina, et al.
Publicado: (2019)

Mutations in p53, p53 protein overexpression and breast cancer survival
por: Rossner, Pavel, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_52k1ttv4orod99l7b5hrm2lci9